Boston, MA, United States of America

Alan David Michelson

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan David Michelson: Innovator in Thrombosis Research

Introduction

Alan David Michelson is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of medical research, particularly in understanding blood clot formation. His innovative work has led to the development of a patented method that enhances the understanding of thrombosis.

Latest Patents

Michelson holds a patent for "Methods, systems, and compositions for determining blood clot formation, and uses thereof." This method is directed to determining a thrombosis function and includes flowing a fluid sample over a surface having a fixed endothelial cell monolayer. The method further includes stimulating the fixed endothelial cell monolayer to induce the formation of a clot, which occurs via interaction between the fixed endothelial cell monolayer and the fluid sample. In response to the clot formation, the method includes determining a thrombosis function associated with the fluid sample and the fixed endothelial cell monolayer. He has 1 patent to his name.

Career Highlights

Throughout his career, Michelson has worked with prestigious institutions such as Harvard College and Children's Medical Center Corporation. His research has been pivotal in advancing the understanding of thrombosis and its implications in various medical conditions.

Collaborations

Michelson has collaborated with notable professionals in his field, including Donald Elliot Ingber and Abhishek Jain. These collaborations have further enriched his research and contributed to the advancement of thrombosis studies.

Conclusion

Alan David Michelson's innovative work in thrombosis research has made a significant impact in the medical field. His patented methods provide valuable insights into blood clot formation, showcasing his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…